More Excellus customers are coming forward after receiving letters notifying them that their Medicare Advantage plans will be discontinued. READ MORE: ...
CMS released its 2024 physician fee schedule final rule Nov. 2, which updates the conversion factor to $32.74, a 3.4% decrease from last year. The announcement was not a welcome one for physician ...
Bristol Myers Squibb (NYSE:BMY) and Novartis (NYSE:NVS) criticized the U.S. government's Inflation Reduction Act (IRA), under which Medicare announced revised prices for their blockbuster therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback